MS drug may shield eyes from damage, new study hopes to prove

This study looks at whether the drug ofatumumab can slow down thinning of the retina (the light-sensitive layer at the back of the eye) in people with relapsing-remitting multiple sclerosis (MS). Researchers will follow 75 adults with MS who are either starting or already taking ofatumumab, measuring changes in their eyes and blood over time. The goal is to see if the drug helps protect vision and reduce nerve damage.